切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - c-RET - ErbB - NMDA receptor - Phospholipases

10 件产品

每页
清除全部
  1. G-749
    A8889 G-749
    Target: Aurora Kinases|FLT3|c-RET
    Summary: FLT3抑制剂
      ≥26.05 mg/mL
      insoluble in H2O
  2. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  3. Mubritinib (TAK 165)
    B1543 Mubritinib (TAK 165)
    中文名: 木利替尼
    Target: ErbB
    Summary: HER2/ErbB2有效抑制剂
      ≥76.9 mg/mL
      insoluble in H2O
  4. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  5. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  6. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O
  7. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    中文名: 瑞戈非尼盐酸盐
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: 酪氨酸激酶抑制剂
      ≥25.95 mg/mL
      insoluble in H2O
  8. Varespladib (LY315920)
    A4356 Varespladib (LY315920)
    中文名: 伐瑞拉迪
    Target: Phospholipases
    Summary: HnsPLA的强效选择性抑制剂
      ≥8.18 mg/mL
      insoluble in H2O
  9. TG101348 (SAR302503)
    A4136 TG101348 (SAR302503)
     2 Citation
    中文名: 费德拉替尼
    Target: FLT3|JAK|c-RET
    Summary: JAK-2抑制剂
      ≥26.23 mg/mL
      insoluble in H2O
  10. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: 多靶点HDAC抑制剂
      ≥21.7 mg/mL
      insoluble in H2O

10 件产品

每页